SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,480.78 |
| Enterprise Value ($M) | 890.61 |
| Book Value ($M) | 577.15 |
| Book Value / Share | 9.05 |
| Price / Book | 2.57 |
| NCAV ($M) | 572.69 |
| NCAV / Share | 8.98 |
| Price / NCAV | 2.59 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.24 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.43 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 25.67 |
| Current Ratio | 25.67 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 651.22 |
| Assets | 655.68 |
| Liabilities | 78.53 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -167.17 |
| Net Income | -152.15 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -134.68 |
| Cash from Investing | -425.03 |
| Cash from Financing | 606.67 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avoro Capital Advisors LLC | 8.90 | 30.17 | |
| 13G/A | Kynam Capital Management, LP | 2.49 | -56.81 | |
| 13G | Price T Rowe Associates Inc /md/ | 7.20 | ||
| 13G/A | Commodore Capital Lp | 7.30 | -28.44 | |
| 13G/A | Fmr Llc | 5.08 | 0.39 | |
| 13D/A | Longitude Capital Partners IV, LLC | 8.40 | 0.39 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 49,893 | 398,228 | 12.53 | |
| 159,287 | 827,255 | 19.25 | |
| 92,905 | 517,761 | 17.94 | |
| 292,044 | 1,027,265 | 28.43 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| TVTX – Travere Therapeutics, Inc. | URGN – UroGen Pharma Ltd. |
| VCEL – Vericel Corporation | VNDA – Vanda Pharmaceuticals Inc. |
| VRCA – Verrica Pharmaceuticals Inc. |
Financial data and stock pages provided by
Fintel.io